DEF: TETE Seeks Shareholder Approval for Extension to Complete Business Combination with Bradbury Capital Holdings

Sentiment:

Proxy Statement


Technology & Telecommunication Acquisition Corporation (TETE) is seeking shareholder approval to extend the deadline for completing a business combination by three months, from April 20, 2025, to July 20, 2025, to allow more time to finalize its proposed merger with Bradbury Capital Holdings Inc.

Delay expectedThe company is seeking an extension to the deadline for completing a business combination, indicating a delay in finalizing a deal.

Summary

  • Technology & Telecommunication Acquisition Corporation (TETE) is seeking shareholder approval to extend the date by which it has to complete a business combination by three months, from April 20, 2025, to July 20, 2025.
  • The extension is needed to allow more time to complete its proposed business combination with Bradbury Capital Holdings Inc.
  • Shareholders will vote on three proposals: the Extension Amendment Proposal, the Trust Agreement Amendment Proposal, and the Adjournment Proposal.
  • The Extension Amendment Proposal seeks to amend TETE's Amended and Restated Articles of Association to allow the extension.
  • The Trust Agreement Amendment Proposal seeks to amend TETE's investment management trust agreement to allow the extension.
  • The Adjournment Proposal allows for adjourning the Extraordinary General Meeting to a later date if necessary to permit further solicitation of proxies.
  • The board of directors believes that the extension is in the best interests of TETE and its shareholders.
  • If the extension is not approved, TETE may be forced to liquidate.
  • As of March 31, 2025, the redemption price per Public Share was approximately $12.63.
  • The closing price of the Public Shares on Nasdaq on April 1, 2025 was $12.00.

Sentiment

Score: 5

Explanation: The document is neutral in tone, presenting the facts of the proposed extension and the associated risks and benefits. The sentiment is neither overly positive nor negative.

Positives

  • The board of directors believes that the extension is in the best interests of TETE and its shareholders.
  • The extension would give TETE additional time to complete a Business Combination.
  • If the market price of the Ordinary Shares were to remain the same until the date of the Extraordinary General Meeting, exercising redemption rights would result in a holder of Public Shares receiving approximately $0.63 more per share than if the Public Shares were sold in the open market.

Negatives

  • If the extension is not approved, TETE may be forced to liquidate.
  • TETE cannot assure shareholders that they will be able to sell their Ordinary Shares in the open market, even if the market price per Public Share is lower than the redemption price stated above, as there may not be sufficient liquidity in its securities when such shareholders wish to sell their shares.

Risks

  • If the Extension Amendment Proposal and the Trust Agreement Amendment Proposal are not approved and the Sponsor does not elect to extend the Termination Date by further funding the Trust Account, or if TETE is otherwise unable to consummate its initial business combination by the Termination Date, TETE will cease all operations except for the purpose of winding up.
  • TETEs securities have been delisted by Nasdaq and are no longer listed on a national securities exchange, which could make it more difficult to consummate the Business Combination.
  • We may not be able to complete an initial business combination with a U.S. target company since such initial business combination may be subject to U.S. foreign investment regulations and review by a U.S. government entity such as the Committee on Foreign Investment in the United States (CFIUS), or ultimately prohibited.

Future Outlook

TETE intends to call an additional extraordinary general meeting of its shareholders to approve a Business Combination at a future date.

Management Comments

  • The board of directors currently believes that there will not be sufficient time before April 20, 2025 to hold a general meeting at which to conduct a vote for shareholder approval of the Proposed Business Combination.
  • Accordingly, our board of directors has determined it is in the best interests of the Company and our shareholders to extend the termination date from April 20, 2025 to the Extended Date.

Industry Context

This announcement is typical for SPACs approaching their initial business combination deadline, as they often seek extensions to provide more time to finalize a deal.

Comparison to Industry Standards

  • Many SPACs, such as Gores Metropoulos II, Inc. and Churchill Capital Corp VII, have sought and obtained extensions to complete their business combinations.
  • The redemption rate of 1,993,697 Public Shares on January 20, 2025, is relatively high, indicating a lack of confidence from some shareholders in the company's ability to complete a successful business combination.
  • The non-redemption agreement with the Sponsor and certain institutional investors is a common tactic used by SPACs to reduce redemptions and ensure that the business combination can be completed.

Related Party Transactions

  • The Sponsor has loaned the Company an aggregate of $2,663,642 for extension payments, which are convertible into 266,364 TETE Units upon consummation of the Business Combination at a price of $10.00 per unit.

Stakeholder Impact

  • Shareholders will have the opportunity to vote on the proposed extension and redeem their shares.
  • If the extension is not approved, shareholders may receive a pro rata share of the Trust Account, but will not participate in any future growth of the company.
  • The Sponsor and the officers, directors and the initial shareholders of TETE waived their rights to participate in any liquidation distribution with respect to the 2,875,000 Founder Shares and 532,500 Ordinary Shares underlying the private placement units held by them.

Next Steps

  • Shareholders will vote on the Extension Amendment Proposal, the Trust Agreement Amendment Proposal, and the Adjournment Proposal at the Extraordinary General Meeting on April 16, 2025.
  • If the extension is approved, TETE will continue to attempt to consummate a Business Combination until the Extended Date.
  • TETE intends to call an additional extraordinary general meeting of its shareholders to approve a Business Combination at a future date.

Key Dates

DateDescription
October 21, 2021TETE incorporated as a Cayman Islands exempted company.
February 8, 2022Date of the Investment Management Trust Agreement between TETE and Continental Stock Transfer & Trust Company.
January 14, 2022Date of letter agreement between TETE and the Sponsor.
January 20, 2022TETE consummated its IPO.
January 18, 2023TETE held an extraordinary meeting of shareholders to approve proposals to extend the Combination Period.
January 20, 2023TETE issued an unsecured promissory note to its Sponsor to extend the Combination Period.
August 2, 2023Date of the amended and restated agreement and plan of merger between TETE and Bradbury Capital Holdings Inc.
July 18, 2023TETE held an extraordinary meeting of shareholders to approve proposals to extend the Combination Period.
June 7, 2024TETE held an extraordinary meeting of shareholders to approve proposals to extend the Combination Period.
January 20, 2025TETE held an extraordinary meeting of shareholders to approve proposals to extend the Combination Period.
January 23, 2025TETEs securities were suspended on Nasdaq with immediate effect.
January 23, 2025TETE Class A ordinary shares, warrants and units were listed and began trading on the Pink Current tier of the OTC Markets.
February 14, 2025Date of the Schedule 13G/A filed by Meteora Capital, LLC.
March 28, 2025Record date for the Extraordinary General Meeting.
March 31, 2025The redemption price per Public Share was approximately $12.63.
March 31, 2025The closing price of the Ordinary Shares on OTC Pink was $12.00.
April 1, 2025The closing price of the Public Shares on Nasdaq was $12.00.
April 4, 2025Date of the proxy statement and first mailing to shareholders.
April 9, 2025Deadline to request materials for the Extraordinary General Meeting.
April 14, 2025Deadline to submit a written request to the Trustee to redeem Public Shares for cash.
April 15, 2025Deadline to submit votes by mail.
April 15, 2025Deadline to submit votes by Internet or telephone.
April 16, 2025Extraordinary General Meeting to be held.
April 20, 2025Original deadline for TETE to complete a business combination.
July 20, 2025Proposed extended deadline for TETE to complete a business combination.

Keywords

business combination, extension, shareholder vote, redemption, TETE, Bradbury Capital Holdings, SPAC

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.